Food and Beverage Business
General News

Cultivated Bioscience raises $5 million in funding to advance yeast-based creamer production

Cultivated Bioscience raises $5 million in funding to advance yeast-based creamer production creamer, dairy-free, Food tech & digital transformation, Health and nutritional ingredients, suppliers, yeast Food and Beverage Business

Cultivated Bioscience has secured $5 million in funding to ramp up production of its yeast-derived creamer for dairy-free products in the food industry. This comes after the company raised $1.5 million in a pre-seed round in September 2022. With the new funding, the company aims to scale up its operation and production capabilities.

The yeast-based cream developed by Cultivated Bioscience is designed to replace additives typically used in traditional dairy-free products. It offers improved texture and stability without compromising on taste. Derived from a patented oleaginous yeast produced through yeast biomass fermentation, the company’s approach focuses on achieving functional and sensory parity rather than replicating dairy cream on a molecular level.

Containing fats, proteins, fibers, and yeast lipid droplets that mimic the structure of milk fat, the yeast cream is not only cost-effective but also easier to produce at scale, according to the company. With successful applications in products like coffee creamers, milk, and ice cream, Cultivated Bioscience now plans to expand its reach to the broader food industry, with a B2B launch scheduled for 2025.

In terms of investor support, Cultivated Bioscience faced some challenges during the seed round. CEO Tomas Turner noted that investors required more convincing and wanted to see tangible results. Chief Commercial Officer Lucie Rein emphasized the importance of highlighting the company’s differentiators and demonstrating scalability and cost-effectiveness through solid techno-economic analysis. The company’s traction with industrial partners also played a crucial role in securing funding.

The seed round was led by Navus Ventures and Founderful, with participation from early investors like HarkCapital and Planted founder Lukas Böni. New investors including Joyful VC, Mandi Ventures, and Zürcher Kantonalbank also joined the funding round. Despite the challenging investment market, 2024 is expected to be a more stable and positive year for VC investments, according to data from Crunchbase.

Overall, Cultivated Bioscience’s focus on innovation and sustainability in the food and beverage industry positions it well for future growth and success. By leveraging cutting-edge technology and strategic partnerships, the company is poised to make a significant impact on the market while addressing key industry trends and regulations.

Related posts

Creating Casein Protein from Potatoes

FAB Team

FrieslandCampina makes investment in precision fermentation technology for lactoferrin production

FAB Team

Introducing VeCollal’s new high protein bar with biomimetic vegan collagen

FAB Team